Emergency Medicine Doctors in Panama City Beach, FL Accepting Medicare

4 Emergency Medicine doctors found. Showing 1 - 4

Dr. William Alan Woolery, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11111 Panama City Beach Parkway, Panama City Beach, FL 32413 Phone: 850-770-3270    Fax: 850-770-3275

Julie Youngblood, ARNP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12007 Panama City Beach Pkwy, Panama City Beach, FL 32407 Phone: 850-234-5151    Fax: 850-234-3303

Franklin Brown Merritt, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14302 Millcole Ave, Panama City Beach, FL 32413 Phone: 334-790-0984

Dr. Jeffrey Baker, DO Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 5821 N Lagoon Dr, Panama City Beach, FL 32408 Phone: 850-258-4048    Fax: 850-236-6400

News Archive

Horizon, AstraZeneca partner to explore oncology-relevant genotypes to identify novel drug targets

Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.

Humana to commence 'Limited Income Newly Eligible Transition' program for CMS

Effective Jan. 1, 2010, Humana will begin administering the Limited Income Newly Eligible Transition (LI-NET) program for the Centers for Medicare & Medicaid Services (CMS). This program allows individuals who receive Medicare's low-income subsidy to also receive immediate prescription drug coverage at the point of sale if they are not already enrolled in a Part D plan.

Concise guide to treat children who have swallowed powerful neodymium magnets

Children who swallow powerful neodymium magnets are at risk of serious complications, requiring emergency evaluation and possible treatment. That's the message of a new clinical algorithm published in the September issue of The Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

COST Action ERNST focuses on taking care of second victims

Patient Safety is a Priority in Europe and has improved over the years. Nevertheless, every year between 8 and 12% of the people admitted to hospitals and around 6% of those in primary care suffer from an adverse event (AE) while receiving healthcare.

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

Read more Medical News

› Verified 1 days ago